Welcome to the updated and revised ‘Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics’ report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies.
This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of co-promotion and co-marketing agreements from 2009 to end of May 2014.
The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either a right or option to co-promote/market the resultant product of the research collaboration. There are also numerous pure co-promotion/marketing deals whereby the products originator takes on a co-promotion/marketing partner in order to maximize a products presence in the marketplace.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all co-promotion and co-marketing deals announced since 2009 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
‘Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics’ report provides the reader with the following key benefits:
‘Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics’ report is intended to provide the reader with an in-depth understanding of the co-promotion and co-marketing trends and structure of deals entered into by leading biopharma companies worldwide.
‘Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics’ includes:
In ‘Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics’, the available contracts are listed by:
Each deal title links via Weblink to an online version of deal record as found in the Current Agreements deals and alliances database, providing easy access to each deal record on demand.
The ‘Co-promotion and Co-marketing Partnering Terms and Agreements’ report provides comprehensive access to records for over 800 co-promotion and co-marketing deals. Analyzing actual contract agreements allows assessment of the following:
Browse more Pharma Strategy Market Research Reports